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Currently, Indonesia is in the fifth rank of highest TB 
prevalence over the world. One of the TB problem is low patients’ 
adherence due to the oral antituberculosis induced hepatotoxicity. 
Polymorphisms of NAT2 and CYP2E1 genes had important role in 
the isoniazid (INH)-induced hepatotoxicity. The aim of this study 
was to evaluate the polymorphisms profile of NAT2 and CYP2E1 
genes associated with hepatotoxicity induced by INH. We used 
cohort design in Public Health Centers and Lung Clinics of 
Yogyakarta and Lampung. The inclusion criteria were adult 
subjects (> 18 yo), newly diagnosed TB and treated by oral 
antituberculosis, normal function of renal and live and willingness 
to participate in this study. Subjects were excluded when having 
positive reaction of  HbsAg test, history of HIV and abnormality of 
renal and liver function. The SNPs of NAT2 and CYP2E1 were 
designed using IPlex method of DNA sequenom. Among 57 TB 
patients, we found 14 patients with higher INH serum 
concentration and experienced increase of ALT-AST. Subjects with  
SNPs of rs 2070676, rs 1329149, rs 3813867, rs 6413432, rs 
8192772, rs 2031920, rs 2515641, rs 8192775, rs 915908 of  
CYP2E1  experienced increase of ALT and AST. Subjects with SNPs  
of rs 1799930, rs1799931, rs1801279, rs1801280, rs1799929 , 
rs1208, rs1041983 of  NAT2 are associated with the increase of 
ALT and AST. The polymorphisms of  CYP2E1 and NAT2 may have 
a role in the mechanisms of INH induced DILI. 
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INTRODUCTION 
Tuberculosis (TB) is still become the 
high burden in Indonesia with the incidence of 
around 300.000 in 2014.  Patients adherence to  
TB treatment is important to get the effective 
treatment and to prevent the occurence of 
multidrug resistent TB (MDR). Some factors 
which could influence patients’ adherence are 
forgetfullness, lack of knowledge, herbal 
medicine use, feeling better and drug side 
effects (Tesfahuneygn et al., 2015).  
Hepatotoxicity is the most frequent of 
drug side effects during the TB treatment. This 
side effect may cause the decrease of adherence 
and patients’ quality of life (Babalik et al., 2012). 
Previous study in India showed that Drug-
induced Liver Disease (DILI) was appeared in 
3.8% and patients’ characteristics such as older 
age and alcohol intake could predict the 
development of DILI (Gaude et al., 2015). 
Moreover, our previous study showed that 
around 7.5% TB patients were considered as 
experiencing early DILI (Atthobari et al., 2013). 
Other previous study showed that gender, 
ethnic and acetylator status of NAT2                 
gene could predict the development of 
hepatotoxicity (Chamorro et al., 2013).  
Currently, many pharmacogenetic studies 
in ethnicities around the world show some 
evidences about the association between 
polymorphisms of NAT2, CYP2E1 and GST1 
genes with INH-induced hepatotoxicity 
(Perwitasari et al., 2014; Santos et al., 2012; 
Guaoua et al., 2014;  An et  al., 2101). The study 
in Moroccans population revealed that the 
most prevalent phenotype of NAT2 and 
CYP2E1 was slow acetylators (72.39%) which 
had hepatotoxicity risk (Guaoua et al., 2014).           
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In Brazilian population, the hepatotoxicity              
was experienced by 6.7% patients and                   
there was significant association between              
slow acetylators of NAT2 and CYP2E1 genes 
and the hepatotoxicity risk (Santos et al., 2012).  
NAT2 haplotypes which have decrease 
of enzyme function due to the slow acetylator 
status are NAT2*5B, NAT2*6A, dan 
NAT2*7B (Higuchi et al., 2007). Some SNPs 
(Single Nucleotide of Polymorphisms) of 
CYP2E1 which are supposed to have 
correlation with antituberculosis-induced 
hepatotoxicity are rs 2070676, rs 1329149, rs 
3813867, rs 6413432, rs 8192772, rs 2031920, rs 
2515641, rs 8192775, rs 915908 (Krishnakumar 
et al., 2010). In Indian population, the              
subjects with GST M1 null and combined GST 
M1 and GST T1 had significant association 
with the hepatotoxicity risk (Gupta et al.,               
2013). Moreover, some genes, such as HLA, 
UGT, NOS, BACH and MAFK were also 
predicted as genes associated with anti-
tuberculosis induced hepatotoxicity due to the 
expression of antioxidant enzymes (Perwitasari 
et al., 2014). 
Our study objectives was to evaluate           
the polymorphisms profile of NAT2 and 
CYP2E1 genes associated with INH- induced 
DILI. 
 
MATERIAL AND METHODS 
We used cohort design with adult-newly 
diagnosed TB patients treated with oral 
antituberculosis as Fixed-Dose Combination 
(Rifampicin, Isoniazid, Pyrazynamide and 
Ethambutol) at Public Health Centers and 
Lung Hospitals of Yogyakarta and Lampung. 
Patients’ characteristics data and laboratory 
results, including INH serum concentration 
were taken from the medical record.  
The SNPs of NAT 2 and CYP2E1 genes 
were designed using Sequenom IPlex SNP 
Genotyping and also according to the previous 
studies (Krishnakumar et al., 2010; Guaoua et 
al., 2014; Mishra et al., 2013; Sheng et al., 2014; 
Xiang et al., 2014; Rana et al., 2014; Gupta et al., 
2013; Santos et al., 2013; Lv et al., 2012; Yamada 
et al., 2009) . SNPs of CYP2E1 were rs 
2070676, rs 1329149, rs 1410897, rs 1961456, rs  
2070675, rs 2070677, rs 2408258, rs 2515642, rs 
3813867, rs 6413432, rs 7092584, rs743535, rs 
8192772, rs 915906, rs 2031920, rs 2515641, rs 
8192775, rs 2249694, rs 2249695, rs 2480259, rs 
743534 and rs 915907. SNPs of NAT2 were rs 
6984200, rs1208, rs1799929, rs1799931, rs 
1799930, rs1801279 and rs1801280. 
Inclusion criteria of this study were 
adult-newly diagnosed patients treated with oral 
antituberculosis, normal function of renal and 
liver at baseline measurement. Subjects were 
excluded when having HIV and diabetes 
mellitus history, liver abnormality history, 
abnormality of renal and liver function, reactive 
results of HBsAg test. DILI was defined as the 
level of ALT and AST was above the upper 
limited number of ALT and AST or ALT or 
AST. 
This study has been approved by 
National of Ethics Committee, National Health 
Institute, Jakarta. All subjects received the 
information about the study and signed the 
consent form. 
Data was analyzed descriptively                  
and linear regression was performed to 
understand the association of between AST-
ALT and INH. 
 
RESULTS AND DISCUSSION 
We recruited 57 adult-newly TB patients 
with the age average is 38.11 (SD= 14.57) and 
body weight avergae is 48.96 (SD=1.2). Most of 
the patients are male (63.16%). The average of 
AST and ALT measured in the end of the 
intensive treatment are 27.23 U/L (SD=13.36 
U/L) and 21.25 U/L (SD=13.14). However, 
the average of ALT and AST increased at the 
end of the intensive treatment are 51.42 
(SD=7.43) and 90.47 (SD=41.7), respectively. 
The average of INH serum concentration was 
14.22 µg/ml (SD=7.08) µg/mL. 
The linear regression test revealed the 
significant association between ALT-AST level 
and INH serum concentration (p<0.05; data 
not shown). The association shows that the 
higher ALT-AST, the higher INH serum 
concentration. This finding is in line with 
previous study which stated that there is 
significant correlation between ALT-AST level 
and INH serum concentration (Nelwan et al., 
2014).  In  contrast,  study of  Jeong et al  
(2015), informed that there were no significant 
differences of antituberculosis serum levels 
between groups with and without 
hepatotoxicity. 
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In the other hand, there were significant 
differences of metabolic ratio of acetyl INH 
and INH. The metabolic ratio of acetyl INH 
and INH was lower in the hepatotoxicity group 
than in the non-hepatotoxicity group.  
Of the 57 patients, there are 14 patients 
(24.56%) who had INH serum level above the 
MTC and the increase of ALT-AST.  Table I 
presents the most frequent genotypes in each 
SNPs of NAT2 and CYP2E1 genes.  
According to the previous studies, the 
SNPs of the NAT2 and CYP2E1 genes are 
mostly associated with DILI in multiethnic 
studies (Guaoua et al., 2014; Mishra et al., 2013; 
Sheng et al., 2014; Xiang et al., 2014; Rana et al., 
2014; Gupta et al., 2013; Santos et al., 2013; Lv 
et al., 2012; Yamada et al., 2009)  
Table II lists the different variants of 
SNPs in NAT2 gene in Indonesia and Moroccan 
population which associated with DILI. 
Among the SNPs rs 1208, rs 1799929, rs 
1799931, rs 1801279 and rs 1801280, the 
genotypes in Indonesia population which 
associated with DILI are different from 
genotypes of Moroccan. In NAT2*12A, the 
subjects with A>G had risk to experience 
DILI. The pattern presents in NAT2*11, *7, 
*14 and *5 in Moroccan population. In our 
study, we did not find variants of rs 1041983, 
(NAT2*13A) which had higher risk of DILI in 
Moroccan population (Guaoua et al., 2014). 
NAT2*5 and *7 were known as the slow 
acetylator in Asian Population (Xiaozhen et al.,  
2012). However the NAT2*11 and *12 A were 
assigned as rapid acetylator (Sharma et al., 
2010). According to the phenotypes of 
NAT2*12A, *11, *7, *5 and *14, most of          
our patients in this study are slow acetylator 
(54%). 
Table I. Most frequent genotype in each SNPs of NAT2 and CYPP2E1 associated with DILI 
 
SNPs Genotype % 
NAT2   
rs1208 AA 70.0 
rs1799929 CC 74.0 
rs1799931 GG 54.0 
rs1801279 GG 92.0 
rs1801280 TT 66.0 
rs 6984200 AT 34.0 
rs 11996129 CT 38.0 
CYP2E1   
rs 2031920 CC 72.0 
rs 2515641 CC 44.0 
rs 8192775 GG 60.0 
rs 6413432 TT 52.0 
rs 8192772 TT 46.0 
rs 915908 AA 10.8 
 





Indonesian population Moroccan population* 
rs1208, NAT*12A AA A > G 
rs1799929, NAT2*11 CC C > T 
rs1799931, NAT2*7 GG G > A 
rs1801279 , NAT2*14 GG G > A 
rs1801280 , NAT2*5 TT T > C 
*(Guaoua et al., 2014) 
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There are two SNPs of NAT2 in our 
study, rs 6984200 and rs 11996129, which are 
associated with high level of ALT-AST and the 
high INH serum concentration. To the best of 
our knowledge, we cannot find previous studies 
which discussed about these two SNPs. 
Table III presents the differences of 
genotype variants between Indonesia and China 
population which associated with DILI. 
Some of our study results have similar 
results to China population. For SNPs 
rs2031920 and rs2515641 of CYP2E1, we 
found that subject with CC genotype developed 
DILI. Also in China, around 63.2% of CC 
experienced the increase of ALT and AST. 
Eventhough there are no significant differences 
of hepatotoxicity and between the variants, 
however, this findings support the evidence 
about the genotype which could cause DILI 
(Tang et al., 2013). 
The SNPs of rs 8192775, rs1329149 and 
rs3813867 show different genotype variants 
which have role in DILI which are GG, CT 
and GG, respectively between Yogyakarta and 
Lampung.  The study findings of Tang et al. 
(2013), Yang et al. (2009) and Costa et al. (2012) 
show different genotype of DILI, which are 
AG, TT and CC, respectively. 
The TT genotype of rs 6413432 in 
Indonesia and India population has a role in 
DILI. According to the rs 8192772, in 
Indonesia population, the TT genotype may 
cause DILI, however in India population,  
there were no genotype of this SNP which 
caused DILI . According to rs 207076, this 
SNP was not associated with DILI in Indonesia 
population, however in India, the genotype CC 
may cause DILI (Krishnakumar et al, 2010). 
We cannot find the genotype of rs15908 
in Indonesia which could induce DILI. But we 
found in China population, the GG genotype 
may cause DILI. 
Our study has limitation due to the small 
sample sizes. Future studies with bigger sample 
size should be conducted. However, we can 
confirm that our study findings show that 
polymorphisms of NAT2 and CYP2E1 genes 
in Indonesia population may cause DILI during 
the INH treatment. There are 24.5% TB 
patients experienced increased of ALT-AST 
with high INH serum concentration.  
Comparing our results with previous 
study in China and Morroccan,  some 
genotypes of SNPs in CYP2E1 and NAT2 
which can cause DILI  in Indonesian 
population are similar.  The prevalence of           
drug induced hepatotoxicity in India is quite 
high. Thus, health proffesionals should be 
aware with this explanation to educate the 
patients about hepatotoxicity symptoms and to 




In this study, we found significant 
association between INH serum concentration 
and increased evel of ALT-AST. The SNPs of 
NAT2 gene which associated with DILI are 
rs1799931, rs1801279, rs1801280, rs1799929, 
rs1208. Moreover, the rs2070676, rs1329149, 
rs3813867, rs6413432, rs8192772, rs2031920, 
rs2515641, rs8192775 of CYP2E1 gene are 
associated with DILI. 
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Indonesian population China population* 
rs2031920  CC CC 
rs2515641  CC CC 
rs8192775  GG AG 
 
*(Tang et al., 2013) 
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